Wednesday, September 4, 2013

MORE SUPPUTATIONS IN GENETIC TARGETING THERAPY

My deep investigation into Hypoxia has led to an interesting set of clinical questions
What is again the role of Mitotane in the treatment of Pancreatic cancer?
can Mitotane add to Anti-VEGF in the treatment of Pancreatic or Renal cancers
Is there a role of AUF1 in monitoring Anti-VEGF therapeutic effect
in other words can AUF1 elevation predicts Diabetic retinopathy.
Role of Geldanamycine in pancreatic and esophageal cancers!
Hummm...need to look into these!

No comments: